Using a combination of genetic approaches in animal models, the team demonstrated that manipulating netrin1 levels ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Key takeawaysUCLA researchers have uncovered a surprising new role for netrin1, a crucial protein in neural development, as a ...
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries and these numbers suggest a ...
"The technology's responsiveness to individual pain levels and real-time adaptation to patient needs ... Nevro's ...
GlobalData on MSN1d
Nevro secures CE mark for AI-based spinal cord stimulation systemUS-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.
WATE Knoxville on MSN1d
‘I’m in pain every day’ Retired Knoxville firefighter seeks workers’ comp solution after career-ending injuryKNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...
The global spinal fusion market is on track for substantial expansion, with recent projections highlighting a significant surge in its valuation. According to the latest market analysis, the spinal ...
NVG-291 has received Fast Track designation in spinal cord injury from the U.S. Food and Drug Administration ... expectations and intentions, results, levels of activity, performance, goals or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback